ENVB
Enveric Biosciences Inc
NASDAQ · Pharmaceuticals
$2.37
-0.26 (-9.89%)
Analyst Consensus
Strong Buy
7 analysts
Price Target
Analyst Price Target
+318.1% upside
Low Target
$5.56
Average Target
$9.91
High Target
$13.09
Current Price
$2.37
Current
$2.37
$2.37
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09